Abortion Opponents Pressure Trump's FDA to Restrict Mifepristone Telehealth Prescriptions
US abortion opponents are expressing growing frustration with the Trump administration's pace in reviewing restrictions on the abortion pill mifepristone, particularly regarding online telehealth prescriptions. This tension was highlighted by a recent mixed ruling from US District Judge David Joseph in a lawsuit brought by Louisiana Attorney General Liz Murrill. While the judge declined to immediately block mail-order access to the pills, he acknowledged the state has a strong case and ordered the FDA to complete its ongoing review. Anti-abortion groups argue that the availability of mifepristone via telehealth undermines state bans in 13 states that prohibit abortion at all stages. Although these groups have primarily targeted the FDA rather than President Trump directly, they criticize the agency's 'stall tactics' and suggest enforcing 19th-century laws to ban mailing the pills. The administration maintains that the regulatory review process requires time, despite pressure from activists who believe current rules render state-level prohibitions ineffective.
Wire timeline
Abortion Opponents Pressure Trump's FDA to Restrict Mifepristone Telehealth Prescriptions
US abortion opponents are expressing growing frustration with the Trump administration's pace in reviewing restrictions on the abortion pill mifepristone, particularly regarding online telehealth prescriptions. This tension was highlighted by a recent mixed ruling from US District Judge David Joseph in a lawsuit brought by Louisiana Attorney General Liz Murrill. While the judge declined to immediately block mail-order access to the pills, he acknowledged the state has a strong case and ordered the FDA to complete its ongoing review. Anti-abortion groups argue that the availability of mifepristone via telehealth undermines state bans in 13 states that prohibit abortion at all stages. Although these groups have primarily targeted the FDA rather than President Trump directly, they criticize the agency's 'stall tactics' and suggest enforcing 19th-century laws to ban mailing the pills. The administration maintains that the regulatory review process requires time, despite pressure from activists who believe current rules render state-level prohibitions ineffective.
AP News